After just seven months, Scott Gottlieb has stamped his own imprint on the FDA and, so far, has confounded fears he would be unduly influenced by President Trump or the pharma industry.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
